Completed NA INTERVENTIONAL 1-arm NCT03610620

Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery (FCM-P)

Does Ex-vivo Fluorescence Confocal Microscopy Allow Faster Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery: A Pilot Study

Sponsor: Julie Dawson

Conditions Basal Cell Carcinoma

Interventions Vivascope 2500 ex-vivo fluorescent confocal microscope

Updated 6 times since 2018 Last updated: Nov 25, 2019 Started: Jun 12, 2017 Primary completion: Aug 9, 2018 Completion: Aug 9, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Basal Cell Carcinoma and is currently completed. Julie Dawson leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2018 — Dec 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

Aug 2018 — Sep 2018 [monthly]

Recruiting NA

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Julie Dawson
Mavig GmbH

Data source: Norfolk and Norwich University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Norwich, United Kingdom